Recurrent Priapism Due to Paliperidone Palmitate Use: A Case Report

被引:0
作者
Kurt, Aydin [1 ]
机构
[1] Nigde Training & Res Hosp, Dept Psychiat, Nigde, Turkey
关键词
ONSET;
D O I
10.5152/pcp.2022.21299
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Priapism is a painful and prolonged erection of the penis without sexual stimulation. Priapism can be seen due to both typical and atypical antipsychotic drug use. A 51-year-old male who was followed up with a diagnosis of schizophrenia for 30 years and was switched from oral aripiprazole to paliperidone palmitate due to psychotic exacerbation was reported in this study. About 1 month after starting the drug, the patient presented to the emergency department with a painful and prolonged penile erection lasting 3-4 hours. Following the diagnosis of priapism by urology, the patient was relieved by intracavernous adrenaline injection and corpus cavernosum drainage and was referred to psychiatric consultation. Since the patient's examination, history, and laboratory tests could not detect a condition that could cause priapism, it was thought that priapism might be due to antipsychotic medication. One week after stopping paliperidone palmitate injection, the patient had another attack of priapism. Ten days after the second priapism, the patient was started on olanzapine, 10 mg/day, which was increased to 20 mg/day in the follow-up. The patient has been using olanzapine 20 mg/day for the past year. He is still psychiatrically stable and has no signs of priapism. To the best of our knowledge, this is the second case of recurrent priapism associated with paliperidone palmitate use.
引用
收藏
页码:355 / 357
页数:3
相关论文
共 19 条
  • [1] Priapism Associated with Aripiprazole and Quetiapine in an 8-Year-Old Boy with Autism
    Adanir, Asli Surer
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 26 (02): : 212 - 213
  • [2] Priapism Associated With Antipsychotics Role of α1 Adrenoceptor Affinity
    Andersohn, Frank
    Schmedt, Niklas
    Weinmann, Stefan
    Willich, Stefan N.
    Garbe, Edeltraut
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (01) : 68 - 71
  • [3] Risperidone-induced priapism
    Ankem, MK
    Ferlise, VJ
    Han, KR
    Gazi, MA
    Koppisch, AR
    Weiss, RE
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2002, 36 (01): : 91 - 92
  • [4] Delayed-onset of psychopharmacologically induced priapism: A cautionary case report
    Birur, Badari
    Fargason, Rachel E.
    Moore, Norman
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2015, 17 : 106 - 106
  • [5] Recurrent priapism associated with single dose of paliperidone palmitate: a case report
    Buyukoz, Derya
    Kabadayi Sahin, Esra
    Tatli, Safiye Zeynep
    Ugurlu, Mustafa
    Karakas Ugurlu, Gorkem
    [J]. ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2017, 18 (05): : 513 - 515
  • [6] Correas Gomez M A, 2000, Actas Urol Esp, V24, P840
  • [7] Ferreira LP., 2020, PRIM CARE COMPANION, V22
  • [8] Priapism induced by various psychotropics: A case series
    Greiner, Timo
    Schneider, Michael
    Regente, Johannes
    Toto, Sermin
    Bleich, Stefan
    Grohmann, Renate
    Heinze, Martin
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2019, 20 (06) : 505 - 512
  • [9] American Urological Association guideline on the management of priapism (Reprinted)
    Montague, DK
    Jarow, J
    Broderick, GA
    Dmochowski, RR
    Heaton, JPW
    Lue, TF
    Nehra, A
    Sharlip, ID
    [J]. JOURNAL OF UROLOGY, 2003, 170 (04) : 1318 - 1324
  • [10] Moodliar S, 2019, AM J THER, V347, P1